Prime Medicine (PRME, $6.7) was one of top quarterly gainers, jumping to $6.7 per share. A.I.dvisor analyzed 881 stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.